company background image
0QB7 logo

Borregaard LSE:0QB7 Stock Report

Last Price

kr184.81

Market Cap

kr18.5b

7D

0.3%

1Y

12.0%

Updated

26 Mar, 2024

Data

Company Financials +

0QB7 Stock Overview

Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally.

0QB7 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Risk Analysis

No risks detected for 0QB7 from our risk checks.

Borregaard ASA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Borregaard
Historical stock prices
Current Share Pricekr184.81
52 Week Highkr192.20
52 Week Lowkr148.00
Beta0.47
1 Month Change0.55%
3 Month Change12.06%
1 Year Change11.98%
3 Year Change0.77%
5 Year Change118.97%
Change since IPO782.14%

Recent News & Updates

Recent updates

Shareholder Returns

0QB7GB ChemicalsGB Market
7D0.3%4.1%2.1%
1Y12.0%-33.0%3.8%

Return vs Industry: 0QB7 exceeded the UK Chemicals industry which returned -33% over the past year.

Return vs Market: 0QB7 exceeded the UK Market which returned 3.8% over the past year.

Price Volatility

Is 0QB7's price volatile compared to industry and market?
0QB7 volatility
0QB7 Average Weekly Movement3.4%
Chemicals Industry Average Movement7.4%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0QB7 has not had significant price volatility in the past 3 months.

Volatility Over Time: 0QB7's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20121,127Per Sørliehttps://www.borregaard.com

Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry.

Borregaard ASA Fundamentals Summary

How do Borregaard's earnings and revenue compare to its market cap?
0QB7 fundamental statistics
Market capkr18.48b
Earnings (TTM)kr870.00m
Revenue (TTM)kr7.13b

21.2x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0QB7 income statement (TTM)
Revenuekr7.13b
Cost of Revenuekr2.55b
Gross Profitkr4.59b
Other Expenseskr3.72b
Earningskr870.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 24, 2024

Earnings per share (EPS)8.72
Gross Margin64.32%
Net Profit Margin12.20%
Debt/Equity Ratio34.7%

How did 0QB7 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

43%

Payout Ratio

Does 0QB7 pay a reliable dividends?

See 0QB7 dividend history and benchmarks
When do you need to buy 0QB7 by to receive an upcoming dividend?
Borregaard dividend dates
Ex Dividend DateApr 12 2024
Dividend Pay DateApr 22 2024
Days until Ex dividend16 days
Days until Dividend pay date26 days

Does 0QB7 pay a reliable dividends?

See 0QB7 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.